Benefits of Evening Primrose Oil

Evidence-Based Benefits

• Cyclical mastalgia — Pruthi et al. (2010) and earlier studies from Cardiff Mastalgia Clinic demonstrated that 3g of EPO daily reduced cyclical breast pain severity in approximately 45% of women; EPO was the standard first-line treatment at UK breast clinics for decades
• Anti-inflammatory action — GLA is converted to DGLA and then to prostaglandin E1 (PGE1), which has anti-inflammatory and vasodilatory effects; this mechanism underlies most of EPO's clinical benefits
• PMS support — several small studies suggest EPO may reduce bloating, irritability, and breast tenderness associated with PMS, though systematic reviews show mixed results overall
• Skin health — GLA deficiency is associated with impaired skin barrier function; supplementation with EPO has shown benefits in atopic dermatitis and general skin hydration in some trials

What the Research Says

Evening primrose oil has been studied extensively for mastalgia and PMS since the 1980s. The Cardiff Mastalgia Clinic pioneered its clinical use, finding that 3g daily provided meaningful relief in cyclical breast pain. Pruthi et al. (2010) conducted a more recent placebo-controlled trial and confirmed EPO's efficacy for mastalgia. For PMS, the evidence is more equivocal — Budeiri et al. (1996) performed a meta-analysis of 7 controlled trials and found that while individual studies showed benefit, the overall evidence was limited by small sample sizes and methodological issues. The GLA mechanism is well-established biochemically: GLA → DGLA → PGE1, shifting the prostaglandin balance away from pro-inflammatory pathways.

Related Conditions